Exclusive: Mediar gains $76M for clinical trials of three fibrosis drugs - Endpoints News
Health
A fi?bro?sis biotech has reeled in $76 mil?lion to get clin?i?cal da?ta on three ex?per?i?men?tal med?i?cines over the next two years. Me?di?ar Ther?a?peu?tics raised the

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Popular Categories

Stay Connected

Loading...